Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Franz Dotzer"'
Autor:
Stefan Früngel, Franz Dotzer, Adnan Kastrati, Jürgen Pache, Albert Schömig, Markus Schwaiger, Melchior Seyfarth, Josef Dirschinger, Kurt Huber, Stefan Martinoff, Stefanie Schulz, Stephan G. Nekolla, Werner Moshage, Julinda Mehilli
Publikováno v:
Circulation. 119:1933-1940
Background— The glycoprotein IIb/IIIa receptor inhibitor abciximab has improved the efficacy of primary percutaneous coronary interventions in patients with acute myocardial infarction. However, it is not known whether abciximab remains beneficial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606566ac0fd87fc9f77da87fb499b076
https://doi.org/10.1161/circulationaha.108.818617
https://doi.org/10.1161/circulationaha.108.818617
Autor:
Julinda Mehilli, Josef Dirschinger, Stefanie Schulz, Adnan Kastrati, Albert Schömig, Gjin Ndrepepa, Raisuke Iijima, Olga Bruskina, Peter B. Berger, Jurriën M. ten Berg, Franz Dotzer, Franz-Josef Neumann
Publikováno v:
Clinical Research in Cardiology. 97:160-168
We investigated how does troponin level (TnT) affect the benefit achieved by abciximab in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) after pretreatment with a high loading dose of clopidogrel. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33fb1c3ba03145ee104f5104c2d9578
https://doi.org/10.1007/s00392-007-0603-z
https://doi.org/10.1007/s00392-007-0603-z
Autor:
Albert Schömig, Hildegard Bollwein, Julinda Mehilli, Helmut Schühlen, Adnan Kastrati, Josef Dirschinger, Franz Dotzer, Jörg Hausleiter
Publikováno v:
American Heart Journal. 151:1248-1254
Background ISAR-REACT was a trial designed to evaluate whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention (PCI) with stent placement after pretreatment with a 600 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d8f7d5cca33bc84b97c40c93fdc340
https://doi.org/10.1016/j.ahj.2005.08.002
https://doi.org/10.1016/j.ahj.2005.08.002
Autor:
Julinda Mehilli, Helmut Schühlen, Josef Dirschinger, Peter B. Berger, Jurriën M. ten Berg, Franz Dotzer, Franz-Josef Neumann, Christian Volmer, Adnan Kastrati, Claus Schmitt, Albert Schömig, Alban Dibra
Publikováno v:
European Heart Journal. 26:1379-1384
Aims In the Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Trial, the use of abciximab in patients undergoing percutaneous coronary intervention (PCI) after pretreatment with 600 mg clopidogrel for >2 h wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b1d615041476d53ef781c52a288f6b
https://doi.org/10.1093/eurheartj/ehi174
https://doi.org/10.1093/eurheartj/ehi174
Autor:
Julinda Mehilli, Albert Schömig, Franz Dotzer, Josef Dirschinger, Jurriën M. ten Berg, Isar-React Study Investigators, Franz-Josef Neumann, Hildegard Bollwein, Steven R. Steinhubl, Adnan Kastrati, Peter B. Berger, David E. Kandzari
Publikováno v:
Journal of the American College of Cardiology. 44(11):2133-2136
Objectives We examined clinical outcomes in the Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment (ISAR-REACT) trial based on the duration of pretreatment with a 600-mg loading dose of clopidogrel. Background
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61c1d92b9b4e5353ced4ff915e2f9db5
Autor:
J. Pache, H. Schühlen, Uwe Heemann, Gisela Pogatsa-Murray, Jörg Hausleiter, J. Dirschinger, Franz Dotzer, Michael Vogeser, Dietlind Zohlnhöfer, Albert Schömig, Julinda Mehilli, Christoph Goos, Adnan Kastrati
Publikováno v:
Circulation. 110:790-795
Background— Despite recent advances in interventional cardiology, including the introduction of drug-eluting stents for de novo coronary lesions, the treatment of in-stent restenosis (ISR) remains a challenging clinical issue. Given the efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cca66c826035812d1b5579b2ec8d1d8
https://doi.org/10.1161/01.cir.0000138935.17503.35
https://doi.org/10.1161/01.cir.0000138935.17503.35
Autor:
Adnan Kastrati, Hildegard Bollwein, Jurriën M. ten Berg, Franz Dotzer, Albert Schömig, Franz-Josef Neumann, Josef Dirschinger, Julinda Mehilli, Peter B. Berger, Helmut Schühlen, Christian Volmer, Meinrad Gawaz
Publikováno v:
New England Journal of Medicine. 350:232-238
Background Whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention after pretreatment with clopidogrel is unknown. Methods We enrolled 2159 patients with coronary artery d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b02504b60455cb0fa212a47d991deafe
https://doi.org/10.1056/nejmoa031859
https://doi.org/10.1056/nejmoa031859
Autor:
J.ürgen Pache, Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Franz Dotzer, J.örg Hausleiter, Martin Fleckenstein, Franz-Josef Neumann, Ulrich Sattelberger, Claus Schmitt, Martina Müller, Josef Dirschinger, Albert Schömig
Publikováno v:
Journal of the American College of Cardiology. 41(8):1283-1288
ObjectivesWe tested the hypothesis that thinner-strut stents are associated with a reduced rate of restenosis when comparing two stents with different design.BackgroundWe have previously shown that, for two stents with similar design, the risk for re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d730ef4da20df9a8016916f4af545d6
Autor:
Adnan Kastrati, Franz Dotzer, Josef Dirschinger, Wolfgang Krämer, Julinda Mehilli, Helmut Schühlen, Jürgen Pache, Jörg Hausleiter, Albert Schömig
Publikováno v:
The American Journal of Medicine. 112:13-18
Purpose We sought to assess whether stenting is a better treatment strategy than percutaneous transluminal coronary angioplasty (PTCA) for lesions in small coronary vessels of diabetic patients. Methods We studied the 100 diabetic patients who were e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343dbfa4b0acd1201707caaa10d65387
https://doi.org/10.1016/s0002-9343(01)01010-5
https://doi.org/10.1016/s0002-9343(01)01010-5
Autor:
Franz Dotzer, Franz-Josef Neumann, Albert Schömig, Josef Dirschinger, Julinda Mehilli, Helmut Schühlen, Martin Fleckenstein, Adnan Kastrati
Publikováno v:
Catheterization and Cardiovascular Interventions. 54:414-419
The objective of this multicenter randomized study was to compare the angiographic and clinical results achieved 1 year after coronary placement of two stent models: the hand-mounted JoStent and the premounted Multi-Link Duet stent. We included 505 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::143d4db26ba23d63a293e1b3651a1e66
https://doi.org/10.1002/ccd.2003
https://doi.org/10.1002/ccd.2003